BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19959816)

  • 21. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.
    Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S
    J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea.
    Zhu C; Johansson M; Karlsson A
    Biochem Biophys Res Commun; 2000 Sep; 276(1):179-82. PubMed ID: 11006103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new mechanism of methotrexate action revealed by target screening with affinity beads.
    Uga H; Kuramori C; Ohta A; Tsuboi Y; Tanaka H; Hatakeyama M; Yamaguchi Y; Takahashi T; Kizaki M; Handa H
    Mol Pharmacol; 2006 Nov; 70(5):1832-9. PubMed ID: 16936229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
    Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
    Horton RA; Vogel KW
    J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity.
    Smal C; Vertommen D; Bertrand L; Ntamashimikiro S; Rider MH; Van Den Neste E; Bontemps F
    J Biol Chem; 2006 Feb; 281(8):4887-93. PubMed ID: 16361699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency.
    Guantay L; Garro C; Siri S; Pansa MF; Ghidelli-Disse S; Paviolo N; Racca A; Nicotra V; Radu C; Bocco JL; Felice R; Jansson KH; Remlinger K; Amador A; Stronach E; Coleman K; Muelbaier M; Drewes G; Gloger I; Madauss K; García M; Gottifredi V; Soria G
    Drug Resist Updat; 2023 Mar; 67():100932. PubMed ID: 36706533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NMR conformation study of the complexes of deoxycytidine kinase (dCK) and 2'-deoxycytidine/2'-deoxyadenosine.
    Maltseva T; Usova E; Eriksson S; Milecki J; Földesi A; Chattopadhayaya J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1225-8. PubMed ID: 11562990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.
    Uitdehaag JC; Sünnen CM; van Doornmalen AM; de Rouw N; Oubrie A; Azevedo R; Ziebell M; Nickbarg E; Karstens WJ; Ruygrok S
    J Biomol Screen; 2011 Oct; 16(9):1007-17. PubMed ID: 21873591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-lymphoblast-specific nucleoside kinase: characterization and comparison with deoxycytidine kinase.
    Yamada Y; Goto H; Ogasawara N
    Int J Biochem; 1985; 17(3):425-8. PubMed ID: 2989022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining.
    Keszler G; Spasokoukotskaja T; Csapo Z; Talianidis I; Eriksson S; Staub M; Sasvari-Szekely M
    Biochem Pharmacol; 2004 Mar; 67(5):947-55. PubMed ID: 15104248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.
    Murphy JM; Armijo AL; Nomme J; Lee CH; Smith QA; Li Z; Campbell DO; Liao HI; Nathanson DA; Austin WR; Lee JT; Darvish R; Wei L; Wang J; Su Y; Damoiseaux R; Sadeghi S; Phelps ME; Herschman HR; Czernin J; Alexandrova AN; Jung ME; Lavie A; Radu CG
    J Med Chem; 2013 Sep; 56(17):6696-708. PubMed ID: 23947754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability.
    Nomme J; Li Z; Gipson RM; Wang J; Armijo AL; Le T; Poddar S; Smith T; Santarsiero BD; Nguyen HA; Czernin J; Alexandrova AN; Jung ME; Radu CG; Lavie A
    J Med Chem; 2014 Nov; 57(22):9480-94. PubMed ID: 25341194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes.
    Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Talianidis I; Eriksson S; Staub M
    Biochem Pharmacol; 2001 Jan; 61(2):191-7. PubMed ID: 11163333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and preclinical pharmacology of a novel dCK inhibitor, DI-87.
    Poddar S; Capparelli EV; Rosser EW; Gipson RM; Wei L; Le T; Jung ME; Radu C; Nikanjam M
    Biochem Pharmacol; 2020 Feb; 172():113742. PubMed ID: 31812677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement for deoxycytidine kinase in T and B lymphocyte development.
    Toy G; Austin WR; Liao HI; Cheng D; Singh A; Campbell DO; Ishikawa TO; Lehmann LW; Satyamurthy N; Phelps ME; Herschman HR; Czernin J; Witte ON; Radu CG
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5551-6. PubMed ID: 20080663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput molecular imaging for the identification of FADD kinase inhibitors.
    Khan AP; Schinske KA; Nyati S; Bhojani MS; Ross BD; Rehemtulla A
    J Biomol Screen; 2010 Oct; 15(9):1063-70. PubMed ID: 20855560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intracellular localization of deoxycytidine kinase.
    Hatzis P; Al-Madhoon AS; Jüllig M; Petrakis TG; Eriksson S; Talianidis I
    J Biol Chem; 1998 Nov; 273(46):30239-43. PubMed ID: 9804782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.